Company / Cost of Revenue
PANACEA LIFE SCIENCES HOLDINGS, INC. Cost of Revenue History
FY2018-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$1.3M
FY2023
5-year range
$1.2M / $2.7M
FY2019-FY2023
Trend
+2.6%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue returned to growth in FY2023 after 2 years of decline, reaching $1M.
Based on SEC 10-K filings.
$1M in FY2023 with a 3-year CAGR of -22.6%.
Improved from $2M to $1M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -22.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -22.6%, indicating a declining trend.
- In FY2023, cost of revenue increased 2.6% year-over-year.
- Peak cost of revenue was recorded in FY2020.
- Lowest cost of revenue in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -3.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $1.3M | +2.6% |
| FY2022 | $1.2M | -19.0% |
| FY2021 | $1.5M | -44.1% |
| FY2020 | $2.7M | +32.9% |
| FY2019 | $2.0M | - |
| FY2018 | $0 | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2023 · SEC Form 10-K · Last checked Jun 29, 2026